Cruz’s situation comes at a delicate time for the Yankees, who are looking to stabilize their bullpen as they push toward the latter part of the season. The news also follows Cruz being placed on the 15-day injured list shortly before a 9-3 victory over the Houston Astros, a move that prompted the team to reshuffle its bullpen. In that transaction, right-hander Michael Fulmer was added to the active roster, filling the spot created by Cruz’s IL designation.
Two well-known specialists—one associated with the Dodgers, the other widely recognized for elbow and sports medicine—are among the physicians Cruz is considering for a second opinion. The Yankees’ own team physician, Dr. Christopher Ahmad, is noted for performing similar procedures, which could factor into the decision if surgery is ultimately recommended. The choice Cruz faces is whether to pursue conservative treatment, continued rest and rehabilitation, or to proceed with Tommy John surgery, a procedure that has long-term implications for a pitcher’s availability.
Tommy John surgery, officially known as ulnar collateral ligament reconstruction, typically requires a lengthy rehabilitation period. If Cruz ultimately undergoes surgery, it could sideline him for the remainder of the current season and potentially impact the following year’s timeline. The decision will hinge on the surgeon’s assessment of the ligament’s integrity and the feasibility of returning to competitive pitching in a timely manner.
From a performance perspective, Cruz enjoyed a productive season prior to the injury. Across 61 appearances, he posted a 3.13 ERA, logged two saves, and earned 19 holds, establishing himself as a reliable option in high-leverage situations. His value to the Yankees extends beyond statistics, as he has been a trusted late-inning arm for manager Aaron Boone, complementing closer David Bednar and other relievers in a bullpen that has leaned on versatility and depth.
The trade deadline added some new faces to the roster, with hitters such as Heliot Ramos and Luis Garcia Jr. arriving to bolster the lineup. The club did not add additional relief pitching at the deadline and, in fact, opted to move a reliever, Camilo Doval, to the Pittsburgh Pirates. The loss of Cruz would leave a notable gap in the bullpen, particularly on the right side, where relief options have been thinner compared to the left-handed contingent led by Brent Headrick.
If Cruz’s prognosis is favorable for a return within the current season, the team will need to navigate lineup and bullpen usage to cover his absence. Paul Blackburn, a right-hander already in the bullpen, could be relied upon to handle setup duties alongside other right-handed options such as Yerry De Los Santos and Justin Topa. However, without Cruz’s trusted presence in high-leverage situations, the Yankees may face increased pressure on their bullpen structure and usage strategy during a stretch run that could hinge on durability and adaptability.
The potential long-term impact for Cruz is equally significant. If surgery is chosen, the road back to pitching would be extended, and there would be a substantial question about his effectiveness upon return. Cruz is still under team control through the 2028 season, providing an opportunity for rehabilitation and potential comeback, but also introducing the risk that the elbow’s healing process may affect velocity, command, and consistency.
In the broader context of the Yankees’ season, the injury to a key reliever underscores the importance of bullpen depth and strategic planning. The team will likely rely on a mix of veteran arms and younger relievers to absorb the workload and maintain competitive integrity as they navigate the remainder of the schedule. The situation will be closely watched by coaches, medical staff, and front-office personnel as they map out contingency plans, assess potential roster moves, and determine the best path forward for both the player and the club.
As the healing process unfolds and second opinions are obtained, the Yankees’ medical and coaching staff will be aligned on a recovery timeline and potential return-to-play scenarios. The priority remains ensuring that Cruz receives the appropriate evaluation and treatment, with the ultimate goal of preserving his career and enhancing the team’s chances of success in the near term and beyond.
